August 16, 2021
Kayoko Saito, Professor, Tokyo Women’s Medical University With the launch of Chugai Pharmaceutical’s Evrysdi (risdiplam), Japan now has three therapies available for the treatment of spinal muscular atrophy (SMA). While the new drug offers the first oral option for the...read more